BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7776544)

  • 1. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
    Morozumi T; Ishida Y; Hori M; Kamada T; Yamagami H; Kozuka T; Kusuoka H; Nishimura T
    Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy.
    Kurata C; Tawarahara K; Taguchi T; Aoshima S; Kobayashi A; Yamazaki N; Kawai H; Kaneko M
    J Nucl Med; 1992 Jan; 33(1):6-13. PubMed ID: 1530969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
    Ohtsuki K; Sugihara H; Kuribayashi T; Nakagawa M
    J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The serial change of the 123I-BMIPP SPECT in patients with hypertrophic cardiomyopathy].
    Okuyama C; Sugihara H; Ito K; Yoneyama S; Terada K; Taniguchi Y; Matsumoto K; Ushijima Y; Nakagawa M; Maeda T
    Kaku Igaku; 1996 Dec; 33(12):1329-36. PubMed ID: 9023439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
    Chen SL; Uehara T; Morozumi T; Yamagami H; Kusuoka H; Nishimura T
    Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
    Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The characteristics of myocardial fatty acid metabolism in patients with left ventricular hypertrophy].
    Isobe N; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iizuka T; Kanazawa N; Wakamatsu S; Arisaka H; Suzuki T; Nagai R; Inoue T; Endo K
    Kaku Igaku; 1999 Sep; 36(7):725-33. PubMed ID: 10547982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
    Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
    Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy.
    Amano Y; Kumita S; Takayama M; Kumazaki T
    AJR Am J Roentgenol; 2005 Aug; 185(2):312-8. PubMed ID: 16037498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy.
    Shimizu M; Yoshio H; Ino H; Taki J; Nakajima K; Bunko H; Takeda R
    Int J Cardiol; 1996 Apr; 54(1):51-9. PubMed ID: 8792185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy.
    Shimonagata T; Nishimura T; Uehara T; Hayashida K; Kumita S; Ohno A; Nagata S; Miyatake K
    Nucl Med Commun; 1993 Nov; 14(11):1005-13. PubMed ID: 8290156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential application of tissue Doppler imaging to assess regional left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with 123I-beta-methyl iodophenyl pentadecanoic acid myocardial scintigraphy.
    Yamada H; Oki T; Yamamoto T; Tanaka H; Tabata T; Wakatsuki T; Nomura M; Ito S; Thomas JD
    Clin Cardiol; 2004 Jan; 27(1):33-9. PubMed ID: 14743854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.